SystImmune is a biopharmaceutical company. It is focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates. They are highly experienced immuno-oncology scientists utilizing several technology platforms to develop world-class advanced antibody-based drug therapies.

Bayer Animal Health GmbH, part of Elanco Animal Health, Inc., is a German company located in Leverkusen. The firm engages in researching and developing of antimicrobials, parasiticides and care products. Elanco Animal Health, Inc. acquired Bayer Animal Health GmbH from Bayer AG on August 03, 2020 for $7,648.93 million.

Sichuan Baili Pharmaceutical Co., Ltd., established on 1996-08-23, Business scope includes licensed projects:pharmaceutical production;Health food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Import and export;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Healthy food(prepackaged)Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Chengdu Bailidot Bio-Pharmaceutical Co., Ltd., established on 2017-02-21, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;medical service;Health food production;Inspection and testing service;Drug import and export;Drug Clinical Trial Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Biochemical product technology research and development;Medical Research and Experimental Development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Orionis Biosciences BV, part of Orionis Biosciences, Inc., is a company headquartered in Ghent, Belgium. The firm operates as a drug discovery and development biotechnology company. It was founded in 2015. Nikolai Kley has been the CEO since the company founding.

La Jolla Institute for Allergy & Immunology is an American private company located in La Jolla, CA. The firm operates as a biomedical research institute helps in understanding of immune system disease. It was founded by Steve Pontell. Erica Saphire is currently the CEO of the company.\nThe company says this about itself: The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease.

Ligandal's mission is to create precision delivery platform to cure and treat disease. We are driving the discovery and delivery of a broad array of gene therapies, genetic materials, and gene-specific payloads with unprecedented precision at the cellular and sub-cellular level. Our ligand discovery engine allows for rapid design of diagnostically-responsive materials, capable of shuttling a variety of nucleic acid and protein payloads (including CRISPR and mRNA) to specific cell types. We are initially applying this technology to indications in hematology, immuno-oncology, and infectious disease.

Xbiome is the first AI pharmaceutical company in China that specializes in intestinal micro-ecology. It is based on intestinal micro-ecology and relies on AI technology to accurately and personally manage the gut health of 1.3 billion people. The company uses artificial intelligence to analyze patient and donor intestinal (gut) flora to more quickly develop effective pharmaceuticals.

Trustees of Dartmouth College, part of Dartmouth College, is a company headquartered in Hanover, NH. The firm operates higher education institutes. It was founded in 1769.

Ningbo Aocheng Biotechnology Co., Ltd., established on 2009-02-16, Business scope includes general items:Biochemical product technology research and development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class II Medical Device Leasing;Class I Medical Device Leasing;software development;Artificial intelligence application software development;Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Network and Information Security Software Development;Information system operation and maintenance services;Wholesale of computer software, hardware and auxiliary equipment;Medical Research and Experimental Development;Conference and Exhibition Services;Technology Import and Export;Import and export;market survey(Does not include foreign investigations);Bidding agency service;marketing planning;Mechanical Parts,Parts sales;Instrument sales;Machinery sales;electronics sales;Experimental analysis instrument sales;software sales;Office Supplies Sales;Glassware Sales;Sales of plastic products;Sales of technical glass products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Class III Medical Device Leasing;Class III medical device business;Production of Class III Medical Devices;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shenzhen Juntuo Biotechnology Co., Ltd., established on 2019-09-17, Business scope includes general business items:Research and development of biological products;Operating import and export business;Research and development of biomedicine,Technical Services;Science and Technology Information Consulting;one type,Class II,Research and development of three types of medical devices;Technical promotion of medical devices;Biological and Medical Technology Research,Bioengineering and biomedical engineering technology development and related technical information consultation;biotechnology research,Promotion and service;biogene technology development;Health and wellness management consulting(Does not contain medical behavior);Biohealth Technology Development,technical consulting;Technical research in the field of biotechnology,research and develop;vaccine,Technical development and technical consultation of reagents and genetic engineering drugs;Pharmaceutical Intermediates(Free of Hazardous Chemicals,In addition to drugs)research and development,Sales,transfer of own technology,And provide relevant technical services and technical advice;Sales of biomass extraction machinery and accessories;laboratory instrument,Development and sales of laboratory reagents and consumables(above laws,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is:production of medicines,wholesale;Manufacture of biomass extraction machinery and accessories;laboratory instrument,Manufacture of laboratory reagents and consumables.food sales(Only sell prepackaged food).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Liaocheng Aorun Biomedical Technology Co., Ltd., established on 2015-05-05, The scope of business includes engaging in technology research and development in the field of biomedical expertise,Technology Promotion,technical consulting,technology transfer,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

AID manufactures and distributes diagnostic products and imaging devices.

Beijing Scitop Bio-tech Co., Ltd. engages in the research and development, production, and sale of compound food additives. It also offers edible probiotic products, and animal and plant probiotic products. The company was founded on September 5, 2003 and is headquartered in Beijing, China.

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

Chengdu Greensignal Biotechnology Co., Ltd., established on 2019-08-20, Business scope includes biotechnology research and development;Sales of medical devices;Medical Technology Development,technical consulting,technology transfer;Pharmaceutical Technology Development;Biological product technology research and development;vegetable sales;flowers,seedlings(Does not contain tree seeds)lease,Sales;Fertilizer sales;Agricultural technology research and development,Technical consulting and technical promotion;Import and export of goods and technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.